sanofi's diabetes drug cuts blood sugar, weight
sanofi's candidate drug lyxumia, or lixisenatide, added to basal insulin, significantly reduced blood sugar levels in type 2 diabetes patients and also led to a loss in weight, data published on tuesday showed.
http://feeds.reuters.com/~r/reuters/healthnews/~3/olpuvvs8u3k/us-diabetes-drug-idustre74u60k20110531
1728
31 May 2011 21:55:24
reuters
health